Clinical Trial Update: Study of a New MVA Vaccine for Hepatitis C Virus [Phase 1]

View source ↗

Summary

A Phase 1 study of a novel MVA vaccine for hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• MVA vaccine for Hepatitis C

Snippet

Sponsor: ReiThera Srl | Conditions: Hepatitis C Infection | Phase 1 | Status: COMPLETED